Julie Smith serves as Executive at Raptor Pharmaceutical Corp, where they oversee executive responsibilities. Since joining the company, Julie Smith has executed 10 insider transactions totaling $576.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 13, 2024 involved transacting 4,682 shares valued at $0.
Julie Smith currently holds 10,778 shares of Raptor Pharmaceutical Corp (RPTP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julie Smith has been a net seller of RPTP stock. They have purchased $0 and sold $576.2K worth of shares.
Julie Smith's most recent insider trade was on Aug 13, 2024, when they sold 4,682 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 21, 2024 | EXEL | $576.2K | Sale | 27,280 | $21.12 | Discretionary |
| May 27, 2021 | EXEL | $0 | Award | 16,424 | $N/A | Discretionary |
| May 21, 2020 | EXEL | $0 | Award | 15,538 | $N/A | Discretionary |
| Oct 25, 2016 | RPTP | $577.6K | Disposition | 64,179 | $9.00 | Discretionary |
| Oct 24, 2016 | RPTP | $411.8K | Tender | 45,759 | $9.00 | Discretionary |
| Sep 22, 2016 | EXEL | $0 | Award | 763 | $N/A | Discretionary |
| Feb 9, 2016 | RPTP | $0 | Award | 64,179 | $N/A | Discretionary |
| Dec 3, 2014 | RPTP | $200.0K | Option Exercise | 37,950 | $5.27 | Discretionary |